Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Jackson

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
American Journal of Respiratory and Critical Care Medicine|January 16, 2015
Reply: IL-33-dependent type 2 inflammation in asthma exacerbationsDavid J Jackson
European Respiratory Review : an Official Journal of the European Respiratory Society|May 25, 2022
Assessing adherence to inhaled therapies in asthma and the emergence of electronic monitoring devicesHetal Dhruve, David J Jackson
The Journal of Allergy and Clinical Immunology. in Practice|January 25, 2022
Rhinovirus Infections and Their Roles in Asthma: Etiology and ExacerbationsDavid J Jackson, James E Gern
The Journal of Allergy and Clinical Immunology|June 2, 2010
The role of viruses in acute exacerbations of asthmaDavid J Jackson, Sebastian L Johnston
Chest|November 8, 2020
ResponseJoanne E Kavanagh, David J Jackson
The Journal of Allergy and Clinical Immunology|June 9, 2015
Asthma exacerbations: Looking back to the futureChristine A Sorkness, David J Jackson
The European Respiratory Journal|August 11, 2022
Living without eosinophils: evidence from mouse and manDavid J Jackson, Ian D Pavord
European Respiratory Review : an Official Journal of the European Respiratory Society|January 27, 2022
Eosinophils and eosinophilic immune dysfunction in health and diseaseDavid J Jackson, Praveen Akuthota, Florence Roufosse
Breathe (Sheffield, England)|April 30, 2019
Over- and under-diagnosis in asthmaJoanne Kavanagh, David J Jackson, Brian D Kent
Expert Opinion on Emerging Drugs|October 4, 2016
Are emerging PGD2 antagonists a promising therapy class for treating asthma?Hugo Farne, David J Jackson, Sebastian L Johnston
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
American Journal of Respiratory and Critical Care Medicine|January 16, 2015
Reply: IL-33-dependent type 2 inflammation in asthma exacerbationsDavid J Jackson
European Respiratory Review : an Official Journal of the European Respiratory Society|May 25, 2022
Assessing adherence to inhaled therapies in asthma and the emergence of electronic monitoring devicesHetal Dhruve, David J Jackson
The Journal of Allergy and Clinical Immunology. in Practice|January 25, 2022
Rhinovirus Infections and Their Roles in Asthma: Etiology and ExacerbationsDavid J Jackson, James E Gern
The Journal of Allergy and Clinical Immunology|June 2, 2010
The role of viruses in acute exacerbations of asthmaDavid J Jackson, Sebastian L Johnston
Chest|November 8, 2020
ResponseJoanne E Kavanagh, David J Jackson
The Journal of Allergy and Clinical Immunology|June 9, 2015
Asthma exacerbations: Looking back to the futureChristine A Sorkness, David J Jackson
The European Respiratory Journal|August 11, 2022
Living without eosinophils: evidence from mouse and manDavid J Jackson, Ian D Pavord
European Respiratory Review : an Official Journal of the European Respiratory Society|January 27, 2022
Eosinophils and eosinophilic immune dysfunction in health and diseaseDavid J Jackson, Praveen Akuthota, Florence Roufosse
Breathe (Sheffield, England)|April 30, 2019
Over- and under-diagnosis in asthmaJoanne Kavanagh, David J Jackson, Brian D Kent
Expert Opinion on Emerging Drugs|October 4, 2016
Are emerging PGD2 antagonists a promising therapy class for treating asthma?Hugo Farne, David J Jackson, Sebastian L Johnston
Pageof 19